Explorations into development of bionic baroreflex system to overcome arterial pressure dysregulation in patients with cervical cord injury
开发仿生压力反射系统克服颈髓损伤患者动脉压失调的探索
基本信息
- 批准号:18100006
- 负责人:
- 金额:$ 70.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (S)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2010
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Central baroreflex failure in spinal cord injuries results in serious orthostatic hypotension. Even the latest medical science fails to provide a fundamental remedy for those patients. Since somatic inputs affect sympathetic activities, we examined if transcutaneous electrical stimulation can feedback control arterial pressure (bionic baroreflex system) in spinalized patients. We identified skin regions capable of increasing arterial pressure in response to electrical stimulation. We then determined the transfer function from the stimulation to arterial pressure responses and developed the bionic baroreflex system. The bionic baroreflex system fully prevented orthostatic hypotension in patients with spinal cord injuries.
脊髓损伤后中枢压力反射障碍导致严重的直立性低血压。即使是最新的医学科学也无法为这些患者提供根本的治疗方法。由于躯体输入影响交感神经活动,我们研究了经皮电刺激是否可以反馈控制脊髓损伤患者的动脉压(仿生压力反射系统)。我们确定了能够增加动脉压的皮肤区域,以响应电刺激。然后,我们确定了从刺激到动脉压力反应的传递函数,并开发了仿生压力反射系统。仿生压力反射系统完全预防脊髓损伤患者的直立性低血压。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inhibition of Tumor Necrosis Factor-α-Induced Interleukin-6 Expression by Telmisartan Through Cross-Talk of Peroxisome Proliferator-Activated Receptor-γ With Nuclear Factor κB and CCAAT/Enhancer- Binding Protein-β
- DOI:10.1161/hypertensionaha.108.126656
- 发表时间:2009-05-01
- 期刊:
- 影响因子:8.3
- 作者:Tian, Qingping;Miyazaki, Ryohei;Sunagawa, Kenji
- 通讯作者:Sunagawa, Kenji
Nanoparticle-Mediated Monocyte-Selective Delivery of Pitavastatin Prevents Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in ApoE-Deficient Mice
纳米颗粒介导的单核细胞选择性递送匹伐他汀可预防 ApoE 缺陷小鼠中血管紧张素 II 诱导的腹主动脉瘤形成
- DOI:
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Katsuki S;et al
- 通讯作者:et al
Endogenous Angiotensin-(1-7) Activity in the Rostral Ventrolateral Medulla Is Enhanced in Spontaneously Hypertensive Rats via Sympathetic Nerve Activity
通过交感神经活动增强自发性高血压大鼠延髓头端腹外侧区的内源性血管紧张素-(1-7) 活性
- DOI:
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Nakagaki T;et al
- 通讯作者:et al
Telmisartan inhibits sympathetic nerve activity through the reduction of oxidative stress and release of GABA in RVLM of hypertensive rats.
替米沙坦通过减少高血压大鼠 RVLM 中的氧化应激和 GABA 释放来抑制交感神经活动。
- DOI:
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Kishi T;Hirooka Y;Sunagawa K.
- 通讯作者:Sunagawa K.
The Reduction of Brain Sigma-1 Receptor Contributes to Sympathetic Hyperactivation in Heart Failure.
大脑 Sigma-1 受体的减少导致心力衰竭时交感神经过度活跃。
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Ito K;Hirooka Y;Sunagawa K.
- 通讯作者:Sunagawa K.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUNAGAWA Kenji其他文献
SUNAGAWA Kenji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUNAGAWA Kenji', 18)}}的其他基金
Functional Analysis of Muscle Specific NAD/NADH Dehydrogenase, and Establishment as a Biomarker for Cardiac Dysfunction.
肌肉特异性 NAD/NADH 脱氢酶的功能分析,以及作为心脏功能障碍生物标志物的建立。
- 批准号:
25670392 - 财政年份:2013
- 资助金额:
$ 70.47万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The role of hypoxia response system in the development of cardiovascular and metabolic diseases
缺氧反应系统在心血管及代谢疾病发生发展中的作用
- 批准号:
23659421 - 财政年份:2012
- 资助金额:
$ 70.47万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Strategic Autonomic Nervous Control Using Artificial Brainstem to Cope With Obstinate Cardiovascular Diseases
使用人工脑干进行战略性自主神经控制来应对顽固性心血管疾病
- 批准号:
15200040 - 财政年份:2003
- 资助金额:
$ 70.47万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of Bionic Baroreflex System for Treatment of Orthostatic Hypotension due to Shy-Drager Syndrome
开发仿生压力反射系统治疗 Shy-Drager 综合征引起的直立性低血压
- 批准号:
11694337 - 财政年份:1999
- 资助金额:
$ 70.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Role of Sympatho-vagal Regulation on Ventricular Arterial Coupling
交感迷走神经调节对心室动脉耦合的作用
- 批准号:
05454281 - 财政年份:1993
- 资助金额:
$ 70.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Roles of baroreflex in controlling energy efficiency of ventricular arterial coupling
压力反射在控制心室动脉耦合能量效率中的作用
- 批准号:
03670458 - 财政年份:1991
- 资助金额:
$ 70.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Efficiency of Cardiac Contraction in Ischemic Heart Studied in Conscious Dogs
在清醒的狗中研究缺血性心脏的心脏收缩效率
- 批准号:
01570493 - 财政年份:1989
- 资助金额:
$ 70.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Effect of mechanical synchrony on ventricular contractility
机械同步性对心室收缩力的影响
- 批准号:
62570398 - 财政年份:1987
- 资助金额:
$ 70.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Optimal left ventricular loading using a realtime imprdance loading system
使用实时阻抗负荷系统优化左心室负荷
- 批准号:
61870038 - 财政年份:1986
- 资助金额:
$ 70.47万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research
相似海外基金
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
- 批准号:
23K24566 - 财政年份:2024
- 资助金额:
$ 70.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
ケメリンによる中枢性血圧制御:新たな高血圧症の病態機序
凯莫瑞控制中枢血压:高血压的新病理机制
- 批准号:
22KJ2649 - 财政年份:2023
- 资助金额:
$ 70.47万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial
心脏毒性乳腺癌治疗 (PROTECT) 试验期间强化血压控制
- 批准号:
10660289 - 财政年份:2023
- 资助金额:
$ 70.47万 - 项目类别:
Getting a GRIP on Hypertension in Uganda: Giving Repetitive Isometric Exercise for Blood Pressure Control
乌干达控制高血压:通过重复等长运动控制血压
- 批准号:
479725 - 财政年份:2023
- 资助金额:
$ 70.47万 - 项目类别:
Operating Grants
Identifying and testing a tailored strategy to achieve equity in blood pressure control in PACT
确定并测试量身定制的策略,以在 PACT 中实现血压控制的公平性
- 批准号:
10538513 - 财政年份:2023
- 资助金额:
$ 70.47万 - 项目类别:
Community Blood Pressure Groups - developing an intervention to improve blood pressure control in Zimbabwe
社区血压小组 - 制定干预措施以改善津巴布韦的血压控制
- 批准号:
MR/Y503198/1 - 财政年份:2023
- 资助金额:
$ 70.47万 - 项目类别:
Research Grant
Development of an implementation-ready antihypertensive self-titration intervention to improve US blood pressure control
开发可立即实施的抗高血压自我滴定干预措施,以改善美国血压控制
- 批准号:
10676839 - 财政年份:2022
- 资助金额:
$ 70.47万 - 项目类别:
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
- 批准号:
22H03308 - 财政年份:2022
- 资助金额:
$ 70.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of an implementation-ready antihypertensive self-titration intervention to improve US blood pressure control
开发可立即实施的抗高血压自我滴定干预措施,以改善美国血压控制
- 批准号:
10524825 - 财政年份:2022
- 资助金额:
$ 70.47万 - 项目类别:
The role of kidney epithelial cells specific EP4 receptors in blood pressure control
肾上皮细胞特异性EP4受体在血压控制中的作用
- 批准号:
10709597 - 财政年份:2022
- 资助金额:
$ 70.47万 - 项目类别: